Search

Search Constraints

You searched for: Author/Creator Dälken, Benjamin

Search Results

1. A specific CD4 epitope bound by tregalizumab mediates activation of regulatory T cells by a unique signaling pathway. Issue 4 (16th December 2014)

2. Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial. Issue 4 (17th January 2018)

3. High thioredoxin‐1 levels in rheumatoid arthritis patients diminish binding and signalling of the monoclonal antibody Tregalizumab. Issue 12 (23rd December 2016)